Evidence map›Paper›PMID 41480807›Full record

ArticleMolecular microbiology2026

The BosR Is Back!

D Scott Samuels, Meghan C Lybecker

Abstract read
In one paragraph

Article in Molecular microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

D Scott SamuelsDivision of Biological and Biomedical Sciences, University of Montana, Missoula, Montana, USA.ORCID 0000-0001-8352-7593
Meghan C LybeckerBacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Funding

PlzA, cyclic-di-GMP and the enzootic cycle for Lyme diseaseU01AI169840 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Christopher Davies, RICHARD T MARCONI · 2023 to 2026
$2.8M
Phage-mediated horizontal gene transfer in Borrelia burgdorferiR01AI173045 · NIAID · UNIVERSITY OF MONTANA · PI Patrick R Secor · 2024 to 2026
$1.8M
Targeting a ubiquitous spirochete bacteriophage to prevent Lyme diseaseR21AI151597 · NIAID · UNIVERSITY OF MONTANA · PI SECOR, PATRICK R · 2020 to 2021
$399k
NIAID NIH HHS R01 AI173045NIAID NIH HHS R21 AI151597NIAID NIH HHS U01 AI169840
6 · The paper itself

Abstract

BosR is a novel nucleic acid-binding protein in the ferric uptake regulator (FUR) family that regulates gene expression in the Lyme disease spirochete Borrelia (Borreliella) burgdorferi. This issue of Molecular Microbiology contains a comprehensive transcriptomic study that keenly defines the regulatory swath of BosR in the vertebrate host of B. burgdorferi. Despite homology to Fur-like and PurR-like orthologs, BosR has traditionally been linked to regulation of RpoS, the alternative sigma factor that controls the regulon required for establishing a vertebrate infection. However, BosR regulates other genes through an RpoS-independent mechanism, which is elegantly elaborated in Grassmann et al., along with clearly demonstrating that BosR does not participate in the defense against oxidative and nitrosative stress in the vertebrate. However, the recently recognized role of BosR as an RNA-binding protein with RNA chaperone activity that regulates gene expression in a post-transcriptional fashion is not wholly appreciated, which clouds the results on determining the DNA-binding site in vivo. Regardless, this seminal study enshrines BosR as a major regulator of gene expression in B. burgdorferi and delineates a multitude of BosR-regulated cellular functions in the spirochete related to its ability to navigate between its tick vector and vertebrate host in nature as well as to persist in these two disparate environments.

Indexed as

Bacterial ProteinsBorrelia burgdorferiGene Expression Regulation, BacterialRepressor ProteinsAnimalsHumansLyme DiseaseRegulonRNA-Binding ProteinsSigma FactorBacterial Proteinsferric uptake regulating proteins, bacterialRepressor ProteinsRNA-Binding ProteinsSigma FactorBorrelia (Borreliella) burgdorferiDNA bindingferric uptake regulator (FUR)gene regulationRNA binding

Identifiers

PMID41480807
PMCPMC12871905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.